Prelude Capital Management, LLC Syneos Health, Inc. Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$34.5 - $42.19 $4.58 Million - $5.6 Million
132,619 New
132,619 $5.59 Million
Q2 2022

Aug 15, 2022
SELL
$63.06 - $84.75 $156,010 - $209,671
-2,474 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$74.15 - $99.36 $519 - $695
-7 Reduced 0.28%
2,474 $200,000
Q4 2021

Feb 14, 2022
SELL
$86.01 - $102.89 $648,085 - $775,276
-7,535 Reduced 75.23%
2,481 $255,000
Q3 2021

Nov 15, 2021
SELL
$84.7 - $96.31 $372,595 - $423,667
-4,399 Reduced 30.52%
10,016 $876,000
Q2 2021

Aug 16, 2021
SELL
$76.44 - $89.57 $320,054 - $375,029
-4,187 Reduced 22.51%
14,415 $1.29 Million
Q1 2021

May 17, 2021
BUY
$67.36 - $80.76 $392,843 - $470,992
5,832 Added 45.67%
18,602 $1.41 Million
Q4 2020

Feb 16, 2021
BUY
$53.08 - $69.86 $96,711 - $127,284
1,822 Added 16.64%
12,770 $870,000
Q3 2020

Nov 16, 2020
BUY
$51.29 - $65.09 $498,436 - $632,544
9,718 Added 790.08%
10,948 $582,000
Q2 2020

Aug 14, 2020
BUY
$34.32 - $62.43 $42,213 - $76,788
1,230 New
1,230 $72,000
Q2 2019

Aug 14, 2019
SELL
$40.81 - $52.42 $21,466 - $27,572
-526 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$36.91 - $55.7 $2,288 - $3,453
62 Added 13.36%
526 $27,000
Q4 2018

Feb 14, 2019
BUY
$36.49 - $51.72 $16,931 - $23,998
464 New
464 $18,000

Others Institutions Holding SYNH

# of Institutions
12
Shares Held
731K
Call Options Held
0
Put Options Held
0
View Full List

About Syneos Health, Inc.

SYNH Quotes by TradingView
  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email